|
|
Blood, 1 July 2004, Vol. 104, No. 1, pp. 51-57.
Prepublished online as a Blood First Edition Paper on March 2, 2004; DOI 10.1182/blood-2003-07-2554.

Submitted July 28, 2003
Accepted February 18, 2004
Activation of the MAP-kinase pathway by c-Kit is PI-3-kinase dependent in hematopoietic progenitor/stem cell lines
Ewa Wandzioch, Charlotte E Edling, Ruth H Palmer, Leif Carlsson, and Bengt Hallberg*
Umea Center for Molecular Medicine, Umea University, Umea, Sweden
Department of Medical Biosciences/Pathology, Umea University, Umea, Sweden
Umea Center for Molecular Pathogenesis, Umea University, Umea, Sweden
* Corresponding author; email: Bengt.Hallberg{at}medbio.umu.se.
The Steel Factor (SF) and its receptor c-Kit play a critical role for various cell types at different levels in the hematopoietic hierarchy. Whether similar or distinct signaling pathways are employed upon c-Kit activation in different cell types within the hematopoietic hierarchy is not known. To study c-Kit signaling pathways in the hematopoietic system we have compared c-Kit downstream signaling events in SF-dependent HSC-like cell lines to that of mast cells. Both Erk and Protein Kinase B (PKB)/Akt are activated by ligand-induced activation of the c-Kit receptor in the HSC-like cell lines. Surprisingly, PI-3-kinase inhibitors block not only PKB/Akt activation, but also activation of Raf and Erk. SF induced activation of Ras is not affected by inhibition of PI-3-kinase. In mast cells and other more committed hematopoietic precursors the activation of Erk by SF is not PI-3-kinase dependent. Our results suggest that a molecular signaling switch occurs during differentiation in the hematopoietic system whereby immature hematopoietic progenitor/stem cells employ a PI-3-kinase sensitive pathway in the activation of both Erk and PKB/Akt, which is then switched upon differentiation to the more commonly described PI-3-kinase independent MAP-kinase pathway.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Adhikari and K. Liu
Molecular Mechanisms Underlying the Activation of Mammalian Primordial Follicles
Endocr. Rev.,
August 1, 2009;
30(5):
438 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Paredes-Gamero, C. M. M. P. Leon, R. Borojevic, M. E. M. Oshiro, and A. T. Ferreira
Changes in Intracellular Ca2+ Levels Induced by Cytokines and P2 Agonists Differentially Modulate Proliferation or Commitment with Macrophage Differentiation in Murine Hematopoietic Cells
J. Biol. Chem.,
November 14, 2008;
283(46):
31909 - 31919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kent, M. Copley, C. Benz, B. Dykstra, M. Bowie, and C. Eaves
Regulation of Hematopoietic Stem Cells by the Steel Factor/KIT Signaling Pathway
Clin. Cancer Res.,
April 1, 2008;
14(7):
1926 - 1930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sampaio, M. Dance, A. Montagner, T. Edouard, N. Malet, B. Perret, A. Yart, J.-P. Salles, and P. Raynal
Signal Strength Dictates Phosphoinositide 3-Kinase Contribution to Ras/Extracellular Signal-Regulated Kinase 1 and 2 Activation via Differential Gab1/Shp2 Recruitment: Consequences for Resistance to Epidermal Growth Factor Receptor Inhibition
Mol. Cell. Biol.,
January 15, 2008;
28(2):
587 - 600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Armstrong, O. Hughes, S. Yung, L. Hyslop, R. Stewart, I. Wappler, H. Peters, T. Walter, P. Stojkovic, J. Evans, et al.
The role of PI3K/AKT, MAPK/ERK and NF{kappa}{beta} signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis
Hum. Mol. Genet.,
June 1, 2006;
15(11):
1894 - 1913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Tomczak, M. Gadjeva, Y. Y. Wang, K. Brown, I. Maroulakou, P. N. Tsichlis, S. E. Erdman, J. G. Fox, and B. H. Horwitz
Defective Activation of ERK in Macrophages Lacking the p50/p105 Subunit of NF-{kappa}B Is Responsible for Elevated Expression of IL-12 p40 Observed after Challenge with Helicobacter hepaticus
J. Immunol.,
January 15, 2006;
176(2):
1244 - 1251.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|